632 related articles for article (PubMed ID: 24709882)
1. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris.
Inoue K; Sugiyama A; Reid PC; Ito Y; Miyauchi K; Mukai S; Sagara M; Miyamoto K; Satoh H; Kohno I; Kurata T; Ota H; Mantovani A; Hamakubo T; Daida H; Kodama T
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):161-7. PubMed ID: 17095712
[TBL] [Abstract][Full Text] [Related]
4. Extracellular ubiquitin levels are increased in coronary heart disease and associated with the severity of the disease.
Ji Y; Yao J; Zhao Y; Zhai J; Weng Z; He Y
Scand J Clin Lab Invest; 2020 May; 80(3):256-264. PubMed ID: 32077763
[No Abstract] [Full Text] [Related]
5. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
[TBL] [Abstract][Full Text] [Related]
6. [Pentraxin 3].
Inoue K
Rinsho Byori; 2011 Jul; 59(7):694-701. PubMed ID: 21874796
[TBL] [Abstract][Full Text] [Related]
7. Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques.
Matsuura Y; Hatakeyama K; Imamura T; Tsuruda T; Shibata Y; Kodama T; Kitamura K; Asada Y
J Atheroscler Thromb; 2012; 19(9):837-45. PubMed ID: 22785134
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
[TBL] [Abstract][Full Text] [Related]
9. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting.
Saygı S; Kırılmaz B; Tengiz İ; Türk UÖ; Yıldız H; Tuzun N; Alioğlu E; Tamer GS; Ercan E
Turk Kardiyol Dern Ars; 2012 Apr; 40(3):205-12. PubMed ID: 22864315
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome.
Wang XH; Liu SQ; Wang YL; Jin Y
Genet Mol Res; 2014 Jun; 13(2):4260-6. PubMed ID: 25036169
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
Kume N; Mitsuoka H; Hayashida K; Tanaka M
J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
[TBL] [Abstract][Full Text] [Related]
12. Characterization of interleukin-33 and matrix metalloproteinase-28 in serum and their association with disease severity in patients with coronary heart disease.
Liu CL; Shen DL; Zhu K; Tang JN; Wang XF; Zhang L; Zhang JY
Coron Artery Dis; 2014 Sep; 25(6):498-504. PubMed ID: 24710352
[TBL] [Abstract][Full Text] [Related]
13. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
Chen N; Zhang JY; Yang SZ; Li YD
J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
[TBL] [Abstract][Full Text] [Related]
14. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion].
Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733
[TBL] [Abstract][Full Text] [Related]
15. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
[TBL] [Abstract][Full Text] [Related]
16. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris.
Li HL; Peng WH; Cui ST; Lei H; Wei YD; Li WM; Xu YW
Clin Chem Lab Med; 2011 Sep; 49(9):1547-54. PubMed ID: 21913793
[TBL] [Abstract][Full Text] [Related]
17. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.
Dongming L; Zuxun L; Liangjie X; Biao W; Ping Y
Clin Chim Acta; 2010 Mar; 411(5-6):406-10. PubMed ID: 20026323
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.
Cimmino G; Ragni M; Cirillo P; Petrillo G; Loffredo F; Chiariello M; Gresele P; Falcinelli E; Golino P
Int J Cardiol; 2013 Sep; 168(2):981-6. PubMed ID: 23157807
[TBL] [Abstract][Full Text] [Related]
19. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
20. [Circulating cytokine measurements by protein chips in patients with acute coronary syndrome].
Mao H; Liu TZ; Wen M; Chen JJ; Li L; Zhu JK
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):219-22. PubMed ID: 19099977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
